A multi-institutional phase II study of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung cancer

S-1 is an oral anticancer fluoropyrimidine agent designed to elevate anticancer activity with a decrease in gastrointestinal toxicity. We conducted a phase II study to evaluate the efficacy and safety of combination chemotherapy with S-1 plus cisplatin in patients with advanced non-small cell lung c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: TOMIMOTO, HIDEKI, HANIBUCHI, MASAKI, OGUSHI, FUMITAKA, OKANO, YOSHIO, SHINOHARA, TSUTOMU, DOI, HIROYUKI, YAMAMOTO, AKIYOSHI, TAKEUCHI, EIJI, YAMAMOTO, AKIHIKO, AZUMA, MASAHIKO, TADA, HIROYA, KANEMATSU, TAKANORI, KAKIUCHI, SOJI, GOTO, HISATSUGU, YANO, SEIJI, NISHIOKA, YASUHIKO, SONE, SABURO
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2011
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3410486/
https://ncbi.nlm.nih.gov/pubmed/22866104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2011.266
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados